Medivir AB (0GP7) Stock Statistics & Valuation Metrics

Medivir AB has a market cap or net worth of kr1.05B. The enterprise value is kr754.42M.

Medivir AB has 624,179,440 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medivir AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Medivir AB is ―. Medivir AB’s PEG ratio is ―.

In the last 12 months, Medivir AB had revenue of ― and earned -88.77M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Medivir AB pays an annual dividend of kr0.285, resulting in a dividend yield of 4.35%

Medivir AB upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).

Medivir AB as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Medivir AB has paid ― in taxes.

Medivir AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Medivir AB has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Medivir AB is ―, which is 11.43% higher than the current price. The consensus rating is ―